Annual Park City Update

Conference Registration Hotel Reservations

Course Focus: Molecular Oncology in Routine Pathology Practice


Overview

This timely course is focused on practical aspects of molecular pathology in routine surgical pathology practice. Case-based presentations will be given by distinguished clinical and pathology faculty from the University of Utah, along with renowned keynote speakers, including Dr. Kimberly H. Allison, professor of Pathology, director of Breast Pathology, and vice chair of Education for the Department of Pathology at Stanford University School of Medicine, and Dr. Neal I. Lindeman, associate professor of Pathology and director of Molecular Diagnostics at Brigham and Women’s Hospital, and director of the Molecular Genetic Pathology Fellowship Program at Harvard Medical School.

In the era of personalized medicine, the fields of pathology and medical oncology are rapidly evolving, affecting how we diagnose and treat patients with cancer. The primary objective of this course is to refresh and expand the knowledge surrounding the role of molecular pathology in patient management. This will include familiarizing practicing anatomic pathologists with the growing list of biomarkers assessed in common cancer types, discussing available assays for various biomarker detection and their respective limitations and tissue requirements, in addition to highlighting how the practice of anatomic pathology is evolving in the era of personalized medicine.

Faculty speakers include expert pathologists in the fields of molecular pathology, cytopathology, hematopathology, neuropathology, genitourinary pathology, and breast pathology, as well as selected clinical specialists in medical oncology. This year’s update features two globally recognized expert keynote speakers, who will discuss the role of molecular pathology in the workup of patients with lung and breast cancers. Molecular pathology updates for all common (and not so common) cancer types, including gastrointestinal, thyroid, genitourinary, and soft tissue malignancies, in addition to melanoma, central nervous system tumors, and hematopathology malignancies, will also be presented.

Please join us in Park City, Utah, for this exciting and timely update from experts in the field to advance and diversify your anatomic pathology knowledge and skills as you learn more about the role of molecular pathology. Enhance your ability to guide the molecular workup of patients with cancer and assist clinical teams in decision-making in the era of personalized medicine.


Keynote Speakers

Kimberly H. Allison, MD

Kimberly H. Allison, MD

Vice Chair of Education, Pathology Department,
Director of Breast Pathology and Breast Pathology Fellowship,
Program Director of Pathology Residency,
Professor of Pathology, Stanford University School of Medicine

Dr. Allison is the Director of Breast Pathology at Stanford and Vice Chair of Education for the Department of Pathology. Her research interests include prognostic/predictive markers in breast cancer, standards in HER2 and ER testing, management of risk lesions, diagnostic criteria and diagnostic agreement in breast pathology and patient communication. She is on the editorial board for the 5th edition of the WHO Classification of Tumours of the Breast, is co-chair of the ASCO/CAP ER/PR Testing in Breast Cancer committee, was on the steering committee for the 2018 ASCO/CAP HER2 Testing Guidelines Update, and serves on the NCCN Breast Cancer Treatment Guidelines committee. She is actively involved in resident/fellow training as Director of the Stanford Breast Pathology Fellowship and Residency Director for the Department of Pathology. Dr. Allison is also a breast cancer survivor and the author of “Red Sunshine; A Story of Strength and Inspiration from a Doctor Who Survived Stage 3 Breast Cancer."

Neal I. Lindeman, MD

Neal I. Lindeman, MD

Vice Chair, Molecular Pathology, Brigham and Women's Hospital
Associate Professor of Pathology,
Director, Molecular Genetic Pathology Fellowship Program, Harvard Medical School

Neal Lindeman, MD, is Vice Chair for Molecular Pathology at the Brigham and Women's Hospital, and Associate Professor of Pathology at Harvard Medical School. Dr. Lindeman is certified by the American Board of Pathology (Anatomic and Clinical Pathology, 1999; Molecular Genetic Pathology, 2001) and the American Board of Clinical Chemistry (Molecular Diagnostics, 2000), and has been practicing Molecular Pathology since 1999, serving as Division Chief and Medical Laboratory Director of Molecular Diagnostics since 2011. His research interests focus on Molecular Oncology, identifying genetic alterations that drive the development and behavior of cancers, and translate those findings into diagnostic applications that enable the proper selection of targeted therapies in precision oncology. Some of his more notable accomplishments include leading Pathology efforts in multidisciplinary projects such as the discovery of oncogenic EGFR mutations as targetable alterations in lung cancer, detection of MYD88 alterations in Waldenstrom's Macroglobulinemia, and the leadership of the Profile pan-cancer genomic sequencing program at the Dana-Farber/Brigham Cancer Center. He has led the development of dozens of clinical molecular diagnostics assays, authored or co-authored over 160 scientific papers, co-chaired an international working group from three professional societies that established, and then updated, evidence-based practice guidelines for molecular pathology of lung cancer, trained scores of residents and fellows, and has served in a leadership capacity in multiple professional societies within Pathology.

Course Directors

Georgios Deftereos, MD

Georgios Deftereos, MD

Associate Professor of Pathology, University of Utah School of Medicine
Section Head, Solid Tumor Molecular Oncology, ARUP Laboratories

Dr. George Deftereos is the section head of solid tumor molecular oncology and a medical director of molecular oncology at ARUP Laboratories. He is also an associate professor at the University of Utah School of Medicine. Dr. Deftereos received his medical degree from the University of Bari Aldo Moro before completing an anatomic and clinical pathology residency at Allegheny Health Network. He then completed both a cytopathology fellowship and a molecular genetic pathology fellowship at the University of Washington. His research interests include epigenetics of solid tumors, minimally invasive precision diagnostics, and molecular testing cytopathology of solid tumors.

Anna P. Matynia, MD

Anna P. Matynia, MD

Associate Professor of Pathology, University of Utah School of Medicine
Subspecialty Director, Solid Tumor Non-NGS Molecular Pathology, ARUP Laboratories

Dr. Anna P. Matynia is a medical director of molecular oncology at ARUP Laboratories and an associate professor at the University of Utah School of Medicine. Dr. Matynia received her medical degree from Jagiellonian University. She then completed a hematopathology residency and fellowship as well as a molecular genetic pathology fellowship at the University of Utah School of Medicine. Her research interests include molecular diagnostics of hematolymphoid and solid tumor malignancies.

Faculty

Devaprabu Abraham, MD

Devaprabu Abraham, MD

Professor of Internal Medicine, Adjunct Professor of Pathology and Surgery, University of Utah School of Medicine

Dr. Dev Abraham completed his graduate and postgraduate training in India and in England, respectively. He joined the University of Utah internal medicine residency program in 1993 and then pursued endocrine fellowship training at the Mayo Clinic in Rochester, Minnesota. Following his fellowship training, he returned to the University of Utah in 1998 and joined as endocrinology faculty in the Department of Medicine and the Veterans Affairs Medical Center (VAMC). He is currently a clinical professor of medicine and serves as an adjunct professor in the departments of surgery and pathology. He is passionate about medical education and is a devoted teacher. He is involved with medical student, resident, and fellowship training in endocrinology locally and nationally. He has been awarded numerous local and international teaching awards, including the prestigious AACE Jack Baskin Endocrine teaching award in 2016. He is a dedicated clinician and is the Director of Thyroid and Parathyroid Tumor Program. He is an expert in performing ultrasound evaluation of thyroid and parathyroid tumors. He is certified by the ECNU/AIUM to perform head and neck ultrasonography. He has developed unique techniques for parathyroid and medullary thyroid cancer localization.

Wallace L. Akerley, MD

Wallace L. Akerley, MD

Professor of Internal Medicine, University of Utah School of Medicine
title, instutution

Dr. Akerley is a medical oncologist who has over 30 years of experience as a principal investigator on numerous clinical research trials and who actively cares for patients with lung cancer. He is the chairman of the Protocol Review and Monitoring Committee at Huntsman Cancer Institute (HCI), Director of the Lung Cancer Disease Center of Excellence at HCI, and a member of the NCCN's Steering Committee for Small Cell Lung Cancer Panel and NSCLC Panel.

Katherine Boylan, MD

Katherine Boylan, MD

Assistant Professor of Pathology, University of Utah School of Medicine
Medical Director, Anatomic Pathology, ARUP Laboratories

Dr. Katherine Boylan is a medical director of anatomic pathology at ARUP Laboratories and an assistant professor at the University of Utah School of Medicine. Dr. Boylan received her medical degree from Charles E. Schmidt College of Medicine at Florida Atlantic University. She completed her residency in anatomic and clinical pathology at the University of Utah School of Medicine, and a fellowship in gastrointestinal and hepatobiliary pathology at the University of Chicago School of Medicine. Dr. Boylan is certified in anatomic and clinical pathology by the American Board of Pathology. She received an honorable mention award from the Rodger C. Haggitt Gastrointestinal Pathology Society for her Gastrointestinal Pathology – 2020 Abstract. Her research interests include sessile serrated polyps and the serrated colon cancer pathway, as well as pathology resident education.

Barbara Chadwick, MD

Barbara Chadwick, MD

Professor of Pathology, University of Utah School of Medicine
Medical Director, Anatomic Pathology and Cytopathology, ARUP Laboratories

Dr. Barbara Chadwick is a medical director of anatomic pathology and cytopathology at ARUP Laboratories and a professor in the department of pathology at the University of Utah. Dr. Chadwick received her MD from Loma Linda University before completing an anatomic and clinical pathology residency at the University of Utah School of Medicine. Following her residency, she completed a pathology fellowship at Loma Linda University and a cytopathology fellowship at the University of Washington. Dr. Chadwick is board certified in anatomic and clinical pathology and cytopathology by the American Board of Pathology. She has received the Joe T. Holden Award for Faculty Excellence and the Papanicolaou Society Pathology-In-Training Research Award. Her research interests include the use of molecular markers in cytopathology, pancreatic and biliary cancer, and cervical cancer screening.

Mary P. Bronner, MD

Mary P. Bronner, MD

Carl R. Kjeldsberg, MD Presidential Endowed Chair Professor of Pathology, University of Utah School of Medicine
Division Chief, Anatomic Pathology and Solid Tumor Molecular Oncology, ARUP Laboratories

Dr. Mary Bronner is the division chief of anatomic pathology and oncology at ARUP Laboratories and the Carl R. Kjeldsberg presidential endowed chair professor of pathology, and division chief of anatomic pathology and oncology at the University of Utah. Dr. Bronner received her MD from the University of Pennsylvania, where she also completed her residency. She is on the editorial board of both Human Pathology and Modern Pathology journals. She has received the Arthur Purdy Stout Prize, has served as president of the GI Pathology Society and as a council member of the United States and Canadian Academy of Pathology. Dr. Bronner specializes in gastrointestinal, hepatic and pancreaticobiliary pathology, and molecular oncology. Her research interests include basic, translational, and clinical GI as well as hepatic and pancreaticobiliary pathology.

Joshua F. Coleman, MD

Joshua F. Coleman, MD

Assistant Professor of Pathology, University of Utah School of Medicine
Medical Director, Molecular Oncology, ARUP Laboratories

Dr. Joshua F. Coleman serves as a medical director of molecular oncology at ARUP Laboratories and an assistant professor at the University of Utah School of Medicine. Dr. Coleman received his medical degree from Case Western Reserve University School of medicine and the completed an anatomic and clinical pathology residency at Cleveland Clinic. Following residency, Dr. Coleman completed a hematopathology fellowship at the University of New Mexico and a molecular genetic pathology fellowship at the University of Utah School of Medicine. He is board certified in anatomic and clinical pathology, hematology, and molecular genetic pathology by the American Board of Pathology. Dr. Coleman has received the Clinical Pathology Resident Education of the Year award. He specializes in cancer genomics, bioinformatics, fluorescence in situ hybridization, and his research interests include the application of bioinformatic technologies, data science, and machine learning in molecular genetic pathology.

Christian J. Davidson, MD

Christian J. Davidson, MD

Assistant Professor of Pathology, University of Utah School of Medicine
Medical Director, Anatomic Pathology, ARUP Laboratories

Dr. Davidson is an assistant professor of pathology at the University of Utah School of Medicine. After receiving his MD from Jefferson Medical College in Philadelphia, he completed his anatomic pathology residency training at Brigham and Women’s Hospital and his neuropathology fellowship at Massachusetts General Hospital, both in Boston. Dr. Davidson is a member of the American Association of Neuropathologists. In addition, he has a longstanding interest in molecular tumorigenesis of brain tumors, specifically the diffuse gliomas and NF2-related tumors.

Allie H. Grossmann, MD, PhD

Allie H. Grossmann, MD, PhD

Associate Professor of Pathology, University of Utah School of Medicine
Medical Director, Anatomic Pathology and Molecular Oncology, ARUP Laboratories

Dr. Allie H. Grossmann is the medical director of anatomic pathology and molecular oncology at ARUP Laboratories and an associate professor at the University of Utah School of Medicine. She graduated from Oregon Health Science University with her doctorate and medical degrees. She then completed an anatomic pathology residency, molecular medicine fellowship, and a molecular genetic pathology fellowship at the University of Utah School of Medicine. Dr. Grossmann is certified by the American Board of Pathology in molecular genetic pathology and anatomic pathology. She is the recipient of the Harry J. Lloyd Charitable Trust Career Development award, the NCI K08 Mentored Clinical Scientist award, and the American Cancer Society Research Scholars Grant. Her research interests include mechanisms of tumorigenesis, metastasis, and the development of targeted and immunotherapies for cancer treatment.

Kristin Hunt Karner, MD

Kristin Hunt Karner, MD

Associate Professor of Pathology, University of Utah School of Medicine
Medical Director, Hematopathology and Molecular Oncology, ARUP Laboratories

Dr. Karner is an associate professor of pathology at the University of Utah School of Medicine. She received her MD from the University of Nebraska and completed her anatomic and clinical pathology residency at the University of New Mexico. She also completed hematopathology and molecular genetic pathology fellowships at the University of New Mexico and is board certified by the American Board of Pathology in anatomic and clinical pathology (AP/CP), as well as hematopathology and molecular genetic pathology. Dr. Karner’s areas of focus include both lymphoid and myeloid malignancies, and her current research interests include genetic aspects of myelodysplastic syndrome and other myeloid malignancies.

Parisa Khalili, MD

Parisa Khalili, MD

Assistant Professor of Pathology, University of Utah School of Medicine
Medical Director, Molecular Oncology, ARUP Laboratories

Dr. Parisa Khalili is a medical director of molecular oncology at ARUP Laboratories and an assistant professor at the University of Utah School of Medicine. She received a master’s degree from McGill University and a medical degree from Tehran university of Medical Sciences. She then completed an anatomic residency and molecular genetic pathology fellowship at the University of New Mexico. Dr. Khalili is board certified in anatomic and clinical pathology and molecular genetic pathology. Her research interests include genomic diagnostics in solid tumors.

Jong Taek Kim, MD, MS

Jong Taek Kim, MD, MS

Assistant Professor of Pathology, University of Utah School of Medicine
Medical Director, Molecular Oncology, ARUP Laboratories

Jong Taek Kim, MD, MS is a medical director of molecular oncology at ARUP Laboratories and an assistant professor of clinical pathology at the University of Utah Department of Pathology. Dr. Kim specializes in molecular oncology and biomedical informatics. He received his master’s degree in biomedical informatics at the University of Florida College of Medicine before completing his medical degree at the University of South Alabama College of Medicine. He then completed an orthopedic surgery residency at the Medical University of South Carolina and an anatomic and clinical pathology residency at the University of Florida College of Medicine. Following that, Dr. Kim finished a fellowship in molecular genetic pathology at Cedars-Sinai Medical Center. He is board certified in anatomic and clinical pathology and molecular genetics pathology. Dr. Kim is a member of the United States and Canadian Academy of Pathology, the American Society for Clinical Pathology, and the College of American Pathologists. His research interests include oncologic genomics by next generation sequencing, bioinformatics, biomedical informatics, and applications of AI methodology in healthcare.

Beatrice Knudsen, MD, PhD

Beatrice Knudsen, MD, PhD

Professor of Pathology, University of Utah
Medical Director, Computational Pathology , ARUP Laboratories

Dr. Beatrice Knudsen is a medical director of computational pathology at ARUP Laboratories and a professor of pathology at the University of Utah. Dr. Knudsen received both her doctorate and medical degrees from Weill Cornell Medical School. She completed a residency at the New York Hospital before completing a laboratory research fellowship at Rockefeller University. Dr. Knudsen is board certified and the recipient of the Creativity Award from the Prostate Cancer Foundation. She specializes in genitourinary pathology and her research interests include mechanisms of cancer metastases and biomarker development.

Peng Li, MD, PhD

Peng Li, MD, PhD

Assistant Professor of Pathology, University of Utah School of Medicine
Medical Director, Hematopathology, ARUP Laboratories

Dr. Peng Li is a medical director of hematopathology at ARUP Laboratories and an assistant professor at the University of Utah School of Medicine. Dr. Li received her doctorate degree in molecular pharmacology and structural biology from Thomas Jefferson University and her medical degree from Peking University Health Science Center. She then completed an anatomic and clinical pathology residency at the University of Utah School of Medicine. Following residency, Dr. Li completed a hematopathology fellowship at Stanford University and a molecular genetic pathology fellowship at Baylor College of Medicine. Dr. Li is board certified in anatomic and clinical pathology, molecular genetic pathology, and hematopathology. Her research interests include genetic aspects of myeloid and lymphoid malignancies and myeloid neoplasms with germline predisposition.

Deepika Sirohi, MD

Deepika Sirohi, MD

Assistant Professor of Pathology, University of Utah School of Medicine
Medical Director, Molecular Oncology, ARUP Laboratories

Dr. Deepika Sirohi is a medical director of molecular oncology at ARUP Laboratories and an assistant professor at the University of Utah School of Medicine. Dr. Sirohi received her medical degree from the Armed Forces Medical College and then completed a residency in anatomic and clinical pathology at the University of Texas Health Science Center. She completed a genitourinary pathology fellowship at the Cedar-Sinai Medical Center and a molecular genetic pathology fellowship at the University of California. Dr. Sirohi is board certified in anatomic and clinical pathology and molecular genetic pathology. Her research interests include genomic alteration in urologic malignancies, viral oncogenesis, and applications of next generation sequencing to solid tumors.


COVID-19 Adherence Policy:

The University of Utah Department of Pathology and ARUP Laboratories are committed to providing a safe and healthy atmosphere for our conference attendees. The Park City AP Update planning committee will work closely with the Lodges at Deer Valley to follow all recommendations from local, state, and federal health authorities and adjust safety measures or the meeting format as needed.

Given the continued prevalence of COVID-19, we are requiring all conference attendees be fully vaccinated before arriving at the Update on February 6, 2022. A self-attestation of vaccination status will be required during the registration process with proof of vaccination status provided upon arrival. Masking during the conference sessions is recommended.

The University of Utah Department of Pathology and ARUP Laboratories reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event of a cancellation or postponement of this conference, registration fees will be refunded in full; however, the University of Utah Department of Pathology and/or ARUP Laboratories is not responsible for any related costs, charges, or expenses incurred by registrants of this conference.

Contact

For more information about this conference, or potential vendor sponsorship opportunities, please contact Breanna Russell at breanna.russell@aruplab.com.